News Headlines Article

Little-known drug may halt multiple sclerosis, Gladstone study finds
San Francisco Business Times

Blocking a specific protein with a little-known, experimental drug restored balance in the immune systems of lab mice, preventing them from developing multiple sclerosis, researchers at San Francisco’s Gladstone Institutes found.

The early research, published Monday in the Journal of Experimental Medicine, could chart a new course for the drug against MS, a potentially fatal disease where the immune system runs amok and attacks nerve cells’ protective covers. But the researchers note that some scientists — including one now at Google Inc.-backed Calico Life Sciences LLC — have thought that enhancing the same protein could slow the aging process.